Literature DB >> 8748010

Bleeding and thrombosis in myeloproliferative disorders: mechanisms and treatment.

R Landolfi1, B Rocca, C Patrono.   

Abstract

Entities:  

Mesh：

Year:  1995        PMID： 8748010     DOI： 10.1016/1040-8428(94)00164-O

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN： 1040-8428            Impact factor:   6.312


× No keyword cloud information.
  13 in total

1.  Hemostatic disorders in a JAK2V617F-driven mouse model of myeloproliferative neoplasm.

Authors:  Lamia Lamrani; Catherine Lacout; Véronique Ollivier; Cécile V Denis; Elizabeth Gardiner; Benoit Ho Tin Noe; William Vainchenker; Jean-Luc Villeval; Martine Jandrot-Perrus
Journal:  Blood       Date:  2014-06-20       Impact factor: 22.113

Review 2.  What is the standard treatment in essential thrombocythemia.

Authors:  Tiziano Barbui
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

Review 3.  Polycythaemia vera and essential thrombocythaemia in the elderly.

Authors:  P J van Genderen; M M Troost
Journal:  Drugs Aging       Date:  2000-08       Impact factor: 3.923

Review 4.  Pathogenesis of cardiovascular events in BCR-ABL1-negative myeloproliferative neoplasms.

Authors:  Alexandre Guy; Johanne Poisson; Chloe James
Journal:  Leukemia       Date:  2021-03-03       Impact factor: 11.528

5.  Haemostatic Profile in Patients of Myeloproliferative Neoplasms-A Tertiary Care Centre Experience.

Authors:  Yatendra Parashar; Rashmi Kushwaha; Ashutosh Kumar; Kamal Agarwal; U S Singh; Mili Jain; S P Verma; A K Tripathi
Journal:  J Clin Diagn Res       Date:  2016-11-01

6.  Fibrin network structure and clot mechanical properties are altered by incorporation of erythrocytes.

Authors:  Kathryn C Gersh; Chandrasekaran Nagaswami; John W Weisel
Journal:  Thromb Haemost       Date:  2009-12       Impact factor: 5.249

7.  JAK2V617F-positive endothelial cells contribute to clotting abnormalities in myeloproliferative neoplasms.

Authors:  S Leah Etheridge; Michelle E Roh; Megan E Cosgrove; Veena Sangkhae; Norma E Fox; Junmei Chen; José A López; Kenneth Kaushansky; Ian S Hitchcock
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-27       Impact factor: 11.205

8.  Thrombocytosis: diagnostic evaluation, thrombotic risk stratification, and risk-based management strategies.

Authors:  Jonathan S Bleeker; William J Hogan
Journal:  Thrombosis       Date:  2011-06-08

9.  A rare clinical syndrome of refractory secondary hypertension, renal artery stenosis and erythrocytosis.

Authors:  Dharmendra Bhadauria; Raj Kumar Sharma; Anupama Kaul; Narayan Prasad; Amit Gupta; Deshrag Gurjar; Apoorva Jain
Journal:  NDT Plus       Date:  2011-03-31

10.  JAK2V617F leads to intrinsic changes in platelet formation and reactivity in a knock-in mouse model of essential thrombocythemia.

Authors:  Catherine M Hobbs; Harriet Manning; Cavan Bennett; Louella Vasquez; Sonia Severin; Lauren Brain; Alexandra Mazharian; Jose A Guerrero; Juan Li; Nicole Soranzo; Anthony R Green; Steve P Watson; Cedric Ghevaert
Journal:  Blood       Date:  2013-10-01       Impact factor: 22.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.